Kempen
Overview
Targets, last 12 months
10
Stocks with targets, last 12 months
9
Total targets
45 #38
Total stocks covered
28 #31
Most covered, last 12 months
| Name | Targets |
|---|---|
| Wihlborgs | 2 |
| Atrium Ljungberg | 1 |
| Balder | 1 |
| Bioinvent | 1 |
| Castellum | 1 |
Price targets from Kempen
Pandox+4.4%PriceTarget162.80 SEK170.00 SEKSep 28Castellum-2.7%PriceTarget133.55 SEK130.00 SEKSep 4Wihlborgs+1.7%PriceTarget68.85 SEK70.00 SEKSep 4Bioinvent+295.1%PriceTarget20.25 SEK80.00 SEKMay 28SLP+23.2%PriceTarget34.10 SEK42.00 SEKMar 30Sagax-0.2%PriceTarget170.40 SEK170.00 SEKMar 30Hufvudstaden+17.8%PriceTarget110.40 SEK130.00 SEKJan 13Balder+42.8%PriceTarget49.02 SEK70.00 SEKJan 13Atrium Ljungberg+44.2%PriceTarget21.50 SEK31.00 SEKJan 13Camurus–PriceTarget666.00 SEK950.00 SEKSep -25Cantargia–PriceTarget1.38 SEK8.00 SEKAug -25Bavarian Nordic–PriceTarget247.40 DKK233.00 DKKAug -25Egetis Therapeutics–PriceTarget9.06 SEK12.00 SEKAug -25Entra–PriceTarget93.00 NOK125.00 NOKAug -25Catena–PriceTarget358.20 SEK500.00 SEKJul -25Gubra–PriceTarget289.00 DKK740.00 DKKJun -25Zealand Pharma–PriceTarget226.00 DKK450.00 DKKJun -25Rockwool–PriceTarget189.30 DKK260.00 DKKJun -25Bioarctic–PriceTarget300.00 SEK350.00 SEKNov -23Biovica–PriceTarget0.30 SEK30.00 SEKJun -23Fabege–PriceTarget65.05 SEK75.00 SEKApr -23SBB–PriceTarget2.60 SEK11.00 SEKApr -23Vicore Pharma–PriceTarget9.52 SEK40.00 SEKMar -23Oncopeptides–PriceTarget1.69 SEK35.00 SEKJul -22Calliditas–PriceTarget208.00 SEK320.00 SEKDec -21Kungsleden–PriceTarget121.10 SEK130.00 SEKSep -21Synact Pharma–PriceTarget17.24 SEK125.00 SEKJun -21Xbrane Biopharma–PriceTarget12.00 SEK180.00 SEKJun -21
| Pandox | 162.80 SEK | 170.00 SEK | +4.4% | Sep 28 |
| Castellum | 133.55 SEK | 130.00 SEK | -2.7% | Sep 4 |
| Wihlborgs | 68.85 SEK | 70.00 SEK | +1.7% | Sep 4 |
| Bioinvent | 20.25 SEK | 80.00 SEK | +295.1% | May 28 |
| SLP | 34.10 SEK | 42.00 SEK | +23.2% | Mar 30 |
| Sagax | 170.40 SEK | 170.00 SEK | -0.2% | Mar 30 |
| Hufvudstaden | 110.40 SEK | 130.00 SEK | +17.8% | Jan 13 |
| Balder | 49.02 SEK | 70.00 SEK | +42.8% | Jan 13 |
| Atrium Ljungberg | 21.50 SEK | 31.00 SEK | +44.2% | Jan 13 |
| Camurus | 666.00 SEK | 950.00 SEK | – | Sep -25 |
| Cantargia | 1.38 SEK | 8.00 SEK | – | Aug -25 |
| Bavarian Nordic | 247.40 DKK | 233.00 DKK | – | Aug -25 |
| Egetis Therapeutics | 9.06 SEK | 12.00 SEK | – | Aug -25 |
| Entra | 93.00 NOK | 125.00 NOK | – | Aug -25 |
| Catena | 358.20 SEK | 500.00 SEK | – | Jul -25 |
| Gubra | 289.00 DKK | 740.00 DKK | – | Jun -25 |
| Zealand Pharma | 226.00 DKK | 450.00 DKK | – | Jun -25 |
| Rockwool | 189.30 DKK | 260.00 DKK | – | Jun -25 |
| Bioarctic | 300.00 SEK | 350.00 SEK | – | Nov -23 |
| Biovica | 0.30 SEK | 30.00 SEK | – | Jun -23 |
| Fabege | 65.05 SEK | 75.00 SEK | – | Apr -23 |
| SBB | 2.60 SEK | 11.00 SEK | – | Apr -23 |
| Vicore Pharma | 9.52 SEK | 40.00 SEK | – | Mar -23 |
| Oncopeptides | 1.69 SEK | 35.00 SEK | – | Jul -22 |
| Calliditas | 208.00 SEK | 320.00 SEK | – | Dec -21 |
| Kungsleden | 121.10 SEK | 130.00 SEK | – | Sep -21 |
| Synact Pharma | 17.24 SEK | 125.00 SEK | – | Jun -21 |
| Xbrane Biopharma | 12.00 SEK | 180.00 SEK | – | Jun -21 |